Abstract:AIM:To investigate the effect of three-dimensional conformal radiotherapy (3-DCRT) in combination with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.METHODS:Forty-eight patients with unresectable recurrent rectal cancer were randomized and treated by 3-DCRT or 3-DCRT combined with FOLFOX4 chemotherapy between September 2001 and October 2003. For the patients without prior radiation history, the initial radiation was given to the whole pelvis by traditional methods with tumor dose of 40 Gy, followed by 3-DCRT for the recurrent lesions to the median total cumulative tumor dose of 60 Gy (range 56-66 Gy); for the post-radiation recurrent patients, 3-DCRT was directly given for the recurrent lesions to the median tumor dose of 40 Gy (36-46 Gy). For patients in the study group, two cycles chemotherapy with FOLFOX4 regimen were given concurrently with radiotherapy, with the first cycle given simultaneously with the initiation of radiation and the second cycle given in the fifth week for patients receiving conventional pelvis radiation or given in the last week of 3-DCRT for patients receiving 3-DCRT directly. Another 2-4 cycles (average 3.6 cycles) sequential FOLFOX4 regimen chemotherapy were given to the patients in the study group, beginning at 2-3 wk after chemoradiation. The outcomes of symptoms relieve, tumor response, survival and toxicity were recorded and compared between the study group and the control group.RESULTS:For the study group and the control group, the pain-alleviation rates were 95.2% and 91.3% (P > 0.05); the overall response rates were 56.5% and 40.0% (P > 0.05); the 1-year and 2-year survival rates were 86.9%, 50.2% and 80.0%, 23.9%, with median survival time of 25 mo and 16 mo (P < 0.05); the 2-year distant metastasis rates were 39.1% and 56.0% (P = 0.054), respectively. The side effects, except peripheral neuropathy which was relatively severer in the study group, were similar in the the two groups and well tolerated.CONCLUSION:Three-dimensional conformal radio-therapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer is a feasible and effective therapeutic approach, and can reduce distant metastasis rate and improve the survival rate.

Effect of Three Dimensional Conformal Radiotherapy Combined with Docetaxel in Treatment of Patients with Esophageal Carcinoma

Effect of the combination of Elemene and concurrent chemoradiation with cisplatin followed by consolidation chemotherapy with cisplatin and fluorouracil for locally advanced esophageal cancer

Three-dimensional Conformal Radiotherapy in Combination with Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.

Clinical Study of Late-Course Three-Dimensional Conformal Radiotherapy for Esophageal Carcinoma

Three-dimensional Conformal Radiotherapy Combined with FOLFOX4 Chemotherapy for Unresectable Recurrent Rectal Cancer

Concurrent Three Dimensional Conformal Radiotherapy and Chemotherapy with DF Regime in the Treatment for 33 Cases with Advanced Esophageal Carcinoma

Efficacy and safety of docetaxel chemotherapy combine with 3-dimensional conformal radiation therapy in treatment of esophageal cancer: a systematic review

Clinical Observation of Concurrent Chemoradiotherapy or Radiation Therapy in Treatment of Patients with Esophageal Carcinoma

The Efficacy of Three-Dimensional Conformal Late Course Accelerated Fractionation Radiotherapy for Esophageal Carcinoma

Clinical Observation of Three Dimensional Conformal Radiotherapy Combined with TPF Regimen Chemotherapy for Advanced Esophageal Cancer

Effects of Three-Dimensional Conformal Radiotherapy on the Esophageal Carcinoma

The Effect and Prognosis of Dimen sional Conformal Radiation Therapy for 1348 Cases Esophageal Carcinoma

Meta-Analysis of the Effect of Clinical Target Volume for Three Dimensional Conformal Radiotherapy for the Treatment of Esophageal Carcinoma

Results of Radiotherapy with Concurrent Docetaxel and Cisplatin in Unresectable Esophageal Carcinoma

Three Dimensional-conformal Radiotherapy Combined Concurrent Chemotherapy with Vinorelbine and Cisplatin for Stage Ⅲ Non-small Cell Lung Cancer

Effect of Docetaxel Combined with Carboplatin in Concurrent Chemoradiotherapy of Advanced Cervical Cancer in Outpatient Clinic

Study of Three-Dimensional Conformal Radiotherapy Combined with Concurrent Pemetrexed Chemotherapy and Erlotinib Maintenance in Treatment of Non-Squamous Cell Carcinoma of Locally Advanced Lung Cancer

The Clinical Observation of Low-Dose Paclitaxel Chemotherapy Combined with Concurrent Radiotherapy in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Clinical observation of docetaxel combined with cisplatin in treatment of advanced esophageal cancer with synchronous radiotherapy

[Therapeutic Effect of Combined Cisplatin and Docetaxel Vs Fluorouracil Regimen with Concurrent Radiotherapy on Advanced Esophageal Carcinoma].

Therapeutic Efficacy of Three-Dimensional Conformal Radiotherapy Combined with Concurrent Weekly Cisplatin-Based Chemotherapy for Locally Advanced Cervical Cancer